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Abstract. Ibuprofen is a Class II Biological Safety Class (BSC) drugs used for relief of 
arthritis, as an analgesic and possesses the effect of antiplatelet. The major problem involves in 
ibuprofen is it has a low solubility and high permeability thus causes an unsatisfactory 
therapeutic effect to humans. Thus, in this work, alteration of ibuprofen’s physicochemical 
properties is conducted by means of cocrystallization technique. Co-crystallizations of 
ibuprofen were prepared with selected coformers using dry grinding and liquid assisted 
grinding (LAG) techniques in different molar ratios while ethanol and propanol were used as a 
solvent. The new crystalline forms were identified and characterized by differential scanning 
calorimetry (DSC), powder X-ray diffraction (PXRD) and fourier transform infrared 
spectroscopy (FTIR). Analysis for Ibuprofen-Citric acid (IBP-CA) system, co-crystal was 
successfully formed in 1:2, 1:3, 2:1 and 3:1 molar ratios for neat grinding method although the 
co-crystal produced is unstable. Meanwhile, for Ibuprofen-Oxalic acid (IBP-OA) system, the 
co-crystal formation was identified only in 1:1, 1:2 and 1:3 molar ratios for the neat grinding 
method. LAG method shows that co-crystal formation was unsuccessful in both solvents for 
IBP-CA, while IBP-OA co-crystal was formed in the molar ratio 1:1, 2:1 and 3:1 in ethanol, 
and 2:1 and 3:1 in propanol. 
1. Introduction 
Co-crystal is structurally homogenous crystalline materials contain two or more neutral building 
blocks that are present in definite stoichiometric amounts [4]. While pharmaceutical co-crystal can be 
defined as co-crystal with one of the co-crystal components as an API and the other components are 
called as co-formers or excipient [5]. In other words, it is a crystalline complex of two or more neutral 
molecular components tied together in the crystal lattice through interactions of the non-covalent bond, 
essentially hydrogen bonding [6]. The resulting multi-component crystalline phase retains the intrinsic 
activity of the parent API. 
 Ibuprofen is an active pharmaceutical ingredient (API) known as non-steroidal anti-inflammatory 
drug (NSAID with low solubility and high permeability thus causes an unsatisfactory therapeutic 
effect to humans. Alteration of the physicochemical properties of crystalline active pharmaceutical 
ingredients (APIs) by introducing a pharmaceutically suitable compound is a present strategy in drug 
formation and dosage optimization [1]. The use of co-crystallization technology in active 
pharmaceutical ingredient (API) crystallizations allows the technology to bring improve 
pharmaceutical products to the market place as well as for the improved drug delivery [2]. It has 
garnered much attention in the pharmaceutical industry since the formation of co-crystals can improve 
the properties of an active pharmaceutical ingredient (API) such as solubility, bioavailability, storage, 
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stability, and manufacturability [3]. In this paper, Ibuprofen is selected as the API and the coformer 
used are Oxalic acid and Citric acid. Cocrystal formation between IBP and coformers are conducted 
using neat grinding and liquid assisted grinding method. The main objective of this paper is to explore 
the cocrystal formation between Ibuprofen and selected coformers as a method to improve the 
physicochemical properties of the model drug. Analysis of thermal and crystallinity properties of 
cocrystal are also examined. 
 
2. Material and Method 
2.1. Material 
Ibuprofen (IBP, MW = 206.29 g/mol) was purchased from Shasun Pharmaceutical Limited, India 
(Batch No.: IB 11070248) (SN Grade). Citric acid (CA, MW = 192.124 g/mol), Oxalic acid           
(OA, MW = 90.0349 g/mol), Ethanol (MW = 46.07 g/mol) and Propanol (1-propanol,                     
MW = 60.1 g/mol) were obtained from Sigma-Aldrich (Selangor, Malaysia). All compounds were 
used as received without further purification. 
2.2. Method 
2.2.1. Sample Preparations 
The samples were prepared using neat grinding and liquid assisted grinding method. Additional three 
drops of solvent, Ethanol was added for the liquid assisted grinding method.  Co-crystal blends of 
Ibuprofen-Citric acid and Ibuprofen-Oxalic acid were prepared by using oscillatory ball milling (Mixer 
Mill MM400, Reysch GmbH, Germany). The ball milling samples were produced by placing 
Ibuprofen-Citric acid and Ibuprofen-Oxalic acid at the molar ratios of 1:1, 1:2, 1:3, 2:1 and 3:1 into  25 
ml milling jars with four 6 mm in diameter of stainless steel balls. Milling is carried out at 30 Hz for 
30 min before it was characterized using various analytical techniques including Differential Scanning 
Calorimetry (DSC), X-ray Powder Diffraction (XPRD) and Fourier Transform Infrared (FTIR) 
Spectroscopy. 
2.2.2. Differential Scanning Calorimetry (DSC) 
DSC thermograms were obtained using DSC 820 (Mettler Toledo Inc., Columbus, USA) under 
nitrogen gas flow of 10 mL/min. Sample powders (approx. 8.5 mg) were analysed in 30 μL non-
hermetic sealed aluminium pans. All samples were analysed between 25 °C and 250 °C at a heating 
rate of 10 °C/min and the melting point was recorded. 
2.2.3. X-ray Powder Diffraction (XPRD) 
XPRD was performed using x-ray diffraction analyser (Rigaku D/Max-2000, Woodlands, USA) using 
Cu Kα radiation (λ = 1.542 Å) in continuous scanning mode. An acceleration voltage and current of 40 
kV and 30 mA were used. Data were collected over an angular range of 5o and 50o 2Ɵ with a scan 
speed of 0.5° over 2°/min. 
2.2.4. Fourier Transform Infrared (FTIR) Spectroscopy 
FTIR analytical method used FTIR spectrophotometer (Perkin Elmer Spectrum One, USA) that 
conducted the optical detection using LiTaO3 detector with CsI beamsplitter that has a wavelength 
range of 7,800-225 cm
-1
. For each sample, the scan is conducted in the range of 500 to 3500 cm
-1
. 
3. Result and Discussion  
3.1. Thermal Analysis of Ibuprofen-Citric Acid and Ibuprofen-Oxalic Acid Co-Crystal Screening 
The screening of the Ibuprofen-Citric acid (IBP-CA) and Ibuprofen-Oxalic acid (IBP-OA) formation 
was carried using the molar ratio 1:1, 1:2, 1:3, 2:1 and 3:1. The ground products from the experiment 
were analyzed using DSC. With DSC, the heat flow into and out of the sample and all the transitions 
or reactions due to energy changes involved can be measured [7]. Figure 1(a) shows the thermogram 
analysis of Ibuprofen-Citric acid (IBP-CA) sample produced using the neat grinding method. Based on 
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figure 1, pure Ibuprofen shows the melting peak at 75.82°C and Citric acid shows the melting peak at 
151.59°C while the melting temperature of Oxalic acid is at 187-195°C. The melting points of pure 
substances were in good agreement with the value published in the literature [3,8,9]. There was 
another peak appeared from the thermogram of pure Oxalic acid at 101.14°C. This is the point where 
Oxalic acid shows dihydrate characteristic. This is due to an adsorption of water molecules on Oxalic 
acid particle [10].Figure 1 also shows that there is a possibility for the formation of co-crystal for the 
molar ratio of 1:2, 1:3, 2:1 and 3:1 from the presence of a peak at the beginning of the thermogram. 
However, peaks at the beginning of the thermogram show the unstable co-crystal formation. The peaks 
for the pure components are also observed where there is a slight shift in the peaks to a lower 
temperature, occurred as a result of interaction induced by thermal energy between the drug and the 
coformer during the DSC scan of the sample [11]. Meanwhile, only peaks for pure components are 
observed for molar ratio 1:1 indicating that the formation of co-crystal is unsuccessful. For Ibuprofen-
Oxalic acid (IBP-OA) system, the possibility of co-crystal formation was identified only in 1:1, 1:2 
and 1:3 molar ratios whereas only peaks for pure components are observed for molar ration 2:1 and 
3:1. 
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Figure 1. Differential scanning calorimetry (DSC) analysis of (a) IBP-Citric acid and (b) IBP-
Oxalic acid in different molar ratio, using neat grinding method showing the possibility of the 
formation of co-crystal. 
 
Figure 2(a) and (b) shows the DSC thermogram for IBP-CA and IBP-OA respectively at different 
ratio prepared using liquid assisted grinding method with ethanol used as the solvent. From the 
thermogram, there is no new peaks are observed for IBP-CA while there are new peaks observed for 
IBP-OA at ratio 1:1. 2:1 and 3:1. However, the peaks for pure components are also observed giving an 
early indication that mixtures of pure components and co-crystal exists. Grinding of IBP-CA assisted 
with propanol also shows no formation of cocrystal occur as shown in figure 3(a) as no new peaks are 
observed. Liquid assisted grinding of IBP-OA using propanol shown in figure 3(b) shows a probability 
for mixtures of pure components and co-crystal to exist at ratio 2:1 and 3:1 as small peaks are 
observed between IBP and Oxalic acid. The melting temperature of IBP-CA is slightly increase as the 
ratio increase as shown in figure 3(a). This indicates a significantly increase on intermolecular bonding 
of pure component with the present of ethanol and propanol solvent. This may potentially be the 
reason of unsuccessful attempt to form IBP-CA cocrystal via LAG method [12]. The IBP and the co-
formers used in this work have more than one pKa values, reflecting the ionization constants of acidic 
and basic moieties of the molecules. According to the ‘rules of three’, the possibility of salt formation 
between drug molecule with wide array coformer candidates, their pKa differences should be more 
than 3 unit (ΔpKa > 3).  The pKa value of Ibuprofen is 4.9. Citric acid has three differences of pKa 
values which are 3.08, 4.74 and 5.40 while Oxalic acid is 1.23 and 4.19 [13]. Thus, there will be a 
various difference of pKa, (∆pKa) between Ibuprofen-Citric Acid and Ibuprofen-Oxalic Acid. Table 1 
below shows the ∆pKa values according to the type of mixtures. It shows that the differences in values 
of Ibuprofen-Citric Acid are less than 3. Therefore, Ibuprofen and Citric acid have a greater probability 
of forming cocrystal instead of salt formation. While for Ibuprofen-Oxalic Acid, one of the value 
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shows the greater value to form salt because of it more than 3. Thus, the mixture of Ibuprofen-Oxalic 
Acid can be in cocrystal form or maybe in salt form [14].  
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Figure 2. Differential scanning calorimetry (DSC) analysis of (a) IBP-Citric acid and (b) IBP-
Oxalic acid in different molar ratio, using liquid assisted grinding method with ethanol solvent. 
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Figure 3. Differential scanning calorimetry (DSC) analysis of (a) IBP-Citric acid and (b) IBP-Oxalic 
acid in different molar ratio, using liquid assisted grinding method with propanol solvent. 
 
Table 1. Difference in pKa, (∆pKa) values of Ibuprofen-Citric Acid and Ibuprofen-Oxalic Acid 
Type of Mixtures (∆pKa) 
Ibuprofen-Citric Acid 
1) 4.91 – 3.08 = 1.83 
2) 4.91 – 4.74 = 0.17 
3) 4.91 – 5.40 = -0.49 
Ibuprofen-Oxalic Acid 
1) 4.91 – 1.23 = 3.68 
2) 4.91 – 4.19 = 0.72 
3.2. Crytalline Phase Transformation and Proton Transfer Determination 
Further investigation was conducted by characterizing the product using XPRD and FTIR to confirm 
the formation of co-crystal. Figure 4(a) and (b) shows the XPRD and FTIR analysis for Ibuprofen-
Citric acid using the dry grinding method. The ratios between IBP and CA were varied 
stoichiometrically i.e. 1:1, 1:2, 1:3, 2:1 and 3:1. In figure 4(a), the XRPD data show that new peaks 
were detected in the ratio of 1:1, 1:3, 2:1 and 3:1. New peaks show the probability of co-crystal 
formation. New peaks are still detected for ratio 1:1 even if the DSC thermogram shows no new peak 
for melting point. No new peaks for 1:2 are observed in the XRPD profile even if there is a peak 
detected using DSC. The inconclusive result is obtained based on the analysis for 1:1 and 1:2 ratio. 
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Figure 4. (a) XPRD profile and (b) FTIR spectrum for IBP-CA at different mole ratio using the dry 
grinding method. 
 
Meanwhile, figure 4(b) shows the trend of FTIR spectrum for IBP-CA at varies ratio for the dry 
grinding method. The spectrums with band lower than 1500cm
-1
 are not shown because it is 
considered as the fingerprint region that is rarely diagnostically useful and rarely used to identify the 
functional group [15]. There are possibilities of proton transfer at both pure component (IBP and CA) 
as both consists of –COOH bond in the molecular structure. There are new peaks at wavenumber 
between 3200-3500cm
-1
 at ratio 1:2, 1:3, 2:1 and 3:1 that belongs to the O-H group. This indicates a 
new interaction occurs between IBP and CA at the respective ratio. Since no solvent is used in dry 
grinding, it can be concluded that no solvates were observed, however, the formation of salt cannot be 
concluded. Based on the ‘rules of three’, according to the ∆pKa values between IBP and CA, there is a 
high probability that co-crystal occurs for ratio 1:2, 1:3, 2:1 and 3:1.  
As for the dry grinding method of IBP-OA, new peaks are observed for ratio 1:1, 1:2 and 1:3. This 
supports the preliminary result shown in DSC thermogram figure 1(b) where new melting 
temperatures were observed. Figure 5(a) shows the XRPD profile having at least 0.2° difference 
between OA and pure components for IBP-OA at ratio 1:1, 1:2 and 1:3 using the dry grinding method. 
There are no new peaks are observed for the ratio of 2:1 and 3:1 for IBP-OA using dry grinding. New 
peaks are observed for every ratio used for IBP-OA prepared using liquid assisted grinding with both 
ethanol and propanol solvents as depicted in figure 5(a) and (b) even though DSC only shows new 
peaks for ratio 1:1, 2:1 and 3:1 for ethanol and 2:1 and 3:1 for propanol. This is probably due to the 
phase transformation of the molecules. Meanwhile, the FTIR spectrum of 1:1, 1:2 and 1:3 IBP-OA 
with ethanol and ratio 2:1 and 3:1 IBP-OA with propanol follows the same trends as depicted in figure 
4(b) where the functional group of COOH and CH3 are present in the compound, with no clear 
indication of OH group present. Thus, the formation of salt cannot be clearly determined. 
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Figure 5. XPRD profile for IBP-OA using (a) dry grinding, (b) liquid assisted grinding using ethanol 
and (c) liquid assisted grinding using propanol at different mole ratio. 
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4. Conclusion 
Formation of Ibuprofen-Citric acid (IBP-CA) and Ibuprofen-Oxalic acid (IBP-OXA) co-crystal was 
detected in the molar ratio 1:2, 1:3, 2:1 and 3:1 and 1:1, 1:2 and 1:3 respectively using the neat 
grinding method. Meanwhile, no IBP-CA co-crystal was formed using LAG method for both solvents. 
IBP-OXA co-crystal was formed in the molar ratio 1:1, 2:1 and 3:1 in ethanol, and 2:1 and 3:1 in 
propanol. Confirmation of co-crystal was made using XRPD analysis and FTIR spectrum 
determination where there is a high possiblity that co-crystal was formed for IBP-CA at ratio of 1:2, 
1:3, 2:1 and 3:1, while salt formation was inconclusive for IBP-OA at ratio of 1:1, 1:2 and1:3 using 
neat grinding method. New peaks were determined using XRPD for IBP-OA in ethanol and propanol 
indicating phase transformation occurs, however, the salt formation cannot be clearly determined. For 
future work, solution crystallization with controlled parameters can be employed in order to assess a 
further details on cocrystal formation. 
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